Back to search
FDAFDA · Food and drugs·Recall number D-0914-2018

RANITIDINE Tablets, USP 150 mg UD 100 tablets (10x10), RX Only, Manufactured by: Amneal Pharmaceuticals, Hauppauge, NY 11788, NDC 63739-489-10

Published March 14, 2018 · Recall initiated: February 26, 2018

Summary

FDA records drug Class II recall D-0914-2018, published March 14, 2018 and initiated February 26, 2018. Recalling firm: Mckesson Packaging Services; Status: Terminated; Reported quantity: 17,192 cartons (1,719,200 tablets); Lot: Lots: 0113064 Exp. 03/2018, 0114628 Exp. 08/2018, 0115189 Exp. 08/2018, 0115462 Exp. 09/2018. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Stability Specifications

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Mckesson Packaging Services
Distributor
Nationwide
Lot
Lots: 0113064 Exp. 03/2018, 0114628 Exp. 08/2018, 0115189 Exp. 08/2018, 0115462 Exp. 09/2018
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was RANITIDINE Tablets, USP 150 mg UD 100 tablets (10x10), RX Only, Manufactured by: Amneal Pharmaceuticals, Hauppauge, NY 11788, NDC 63739-489-10 recalled?

Yes. FDA published recall D-0914-2018 on March 14, 2018. Reported hazard: Failed Stability Specifications

What should I do if I have this product?

Voluntary: Firm initiated · Letter